The US FDA has scheduled a Pharmacy Compounding Advisory Committee (PCAC) meeting for Thursday, June 23, 2016. The Committee will discuss six bulk drug substances that were nominated for inclusion on the section 503A bulk drug substances list, also known as the “Bulk Substances Allowed List.” The Committee will be provided with follow-up to discussions from previous meetings, including information about obtaining access to investigational new drugs under expanded access programs.

See the SAC Tracker report